"Ho hlakile" ho bolela'ng?
Phoofolo ha e jare phetoho ea phetoho. E ke ke ea hlahisa lefu lena mme e ke ke ya e fetisa.
Centronuclear Myopathy (CNM) is a genetic disorder affecting Border Collies, characterized by muscle weakness and exercise intolerance. A DNA test for CNM is essential for responsible breeding, helping to identify carriers and reduce the risk of this debilitating condition. This simple yet effective test enables dog owners and breeders to make informed decisions, ensuring healthier puppies. By understanding the genetic predisposition to CNM, owners can provide better care and management for affected dogs. Regular screening through DNA testing not only promotes the health of individual dogs but also contributes to the overall well-being of the Border Collie breed. Invest in a CNM DNA test today to safeguard your canine companion’s future.
Centronuclear Myopathy (CNM) is a genetic disorder affecting Border Collies, characterized by muscle weakness and exercise intolerance. A DNA test can identify carriers and affected dogs, enabling breeders to make informed decisions to reduce the prevalence of this condition. Early detection through genetic testing can help owners manage symptoms and improve the quality of life for affected pets. Responsible breeding practices based on test results play a crucial role in preserving the health of the breed. Overall, DNA testing for CNM enhances breed welfare and promotes healthier generations of Border Collies.
Teko ena ea DNA e kenyelelitsoe ho qala ka pakete ea rona Basic - hape ke karolo ea lipakete Basic, Standard, Advanced, Complete.
Sheba Liphutheloana tsa Tlhahlobo ea DNA →Centronuclear Myopathy (CNM) is a hereditary muscle disorder found in Border Collies. Characterized by weakness and muscle atrophy, this genetic condition significantly affects the dog's motor capabilities and overall quality of life. CNM results from mutations in specific genes leading to improper muscle fiber development and function.
Dogs affected by CNM typically exhibit clinical signs from a young age. Common symptoms include muscle weakness, reduced physical activity, exercise intolerance, abnormal gait, and muscle wasting. Severely affected dogs may have difficulty standing or walking, potentially impacting their ability to perform routine daily activities.
CNM in Border Collies is inherited in an autosomal recessive manner. This means a dog must inherit two copies of the mutated gene—one from each parent—to exhibit symptoms. Dogs carrying only one copy of the mutation (carriers) do not typically show signs but can pass the mutation onto offspring.
DNA testing is essential for identifying the CNM mutation in Border Collies. Early identification of affected and carrier dogs helps breeders make informed decisions, preventing the spread of the condition. DNA testing enables responsible breeding practices, assisting in reducing and eventually eliminating the occurrence of this debilitating condition.
The DNA test clearly distinguishes three genetic statuses:
Breeders are advised to conduct CNM DNA testing in breeding dogs before mating. Clear mating strategies should be selected to avoid producing affected puppies. Owners of Border Collies should consult veterinarians and genetic specialists for guidance on managing dogs diagnosed with CNM, ensuring the best possible quality of life.
Phoofolo ha e jare phetoho ea phetoho. E ke ke ea hlahisa lefu lena mme e ke ke ya e fetisa.
Che. Ka kakaretso phoofolo ena e phetse hantle empa e ka fetisetsa phetoho eo ho eona bana.
E na le likopi tse peli tse fetotsoeng. Matšoao a kliniki a lebelletsoe ho latela lefu lena. Ha ea lokela ho hōlisoa.
Mafu a mang a amahanngoa le thobalano, kahoo polelo ea bona e fapana ho latela thobalano ea phoofolo.
This DNA test detects the mutation associated with Centronuclear Myopathy In Border Collie (CNM) in order to identify clear, carrier, or at-risk animals.
Teko ea DNA e thusa bahlahisi ho rera ho nyalana ho sireletsehileng le ho fokotsa kotsi ea ho fetisetsa phetoho ho bana.
Mokhoa oa lefa o tlalehiloeng bakeng sa tlhahlobo ena ke Autosomal Recessive.
This test analyses the mutation DNM2 c.1393C>T.
Eseng hakaalo. Tlhaloso e itšetlehile ka mokhoa oa lefa le genotype e hlahisoang.
Böhm Johann, Barthélémy Inès, Landwerlin Charlène, BlanchardGutton Nicolas, Relaix Frédéric, Blot Stéphane, Laporte Jocelyn, Tiret Laurent. A dog model for centronuclear myopathy carrying the most common DNM2 mutation. Dis Model Mech. 2022 Apr 1;15(4):dmm049219. doi: 10.1242/dmm.049219. Epub 2022 Apr 14.
Lekunutu la hao, khetho ea hao
Re sebelisa li-cookies tsa bohlokoa ho tsamaisa webosaete. Li-cookie tsa boikhethelo (joalo ka bafani ba litaba tse kentsoeng) li koetsoe ka mokhoa oa kamehla, 'me li ka lumelloa feela ha u lumela. U ka fetola khetho ea hau ka nako efe kapa efe u sebelisa konopo ea "Cookies".
E hlokahala bakeng sa likarolo tsa mantlha le polokeho. E lumelletsoe kamehla.
E ntlafatsa likarolo tse kang ho boloka lintho tseo u li ratang kapa tseo e seng tsa papatso.
E re thusa ho utloisisa tšebeliso ea sebaka sa marang-rang. E emisitsoe ka ho sa feleng.
Papatso/ho sala morao libakeng tsohle (lifitio/limmapa tse ling tse kentsoeng). E emisitsoe ka ho sa feleng.